The Impact of Obesity on Breast Cancer Development in Women: A Study from Kirkuk Governorate, Iraq
Obesity and breast cancer
DOI:
https://doi.org/10.29409/zmbp8e24Keywords:
Breast cancer, Obesity, Obesity levelsAbstract
Objective: Breast cancer (BC) is a malignant tumor arising in breast tissue due to abnormal cell growth and has the ability to spread to other body parts. It is the second most prevalent cancer, and its incidence rate among women has significantly increased, prompting research into contributing factors. Obesity is recognized as a critical factor linked to the development and dissemination of this disease. This research aims to understand the potential impact of obesity on BC development in women.
Methods: A statistical analysis was conducted with 130 women diagnosed with breast cancer to evaluate the relationship between obesity levels and the development and dissemination of BC among obese women in Iraq (Kirkuk governorate). Data were collected via a specifically designed questionnaire, which classified obesity levels as moderate or high. SPSS Statistics software was used for data processing and analysis. Relationships and differences among the variables were assessed via the chi-square test, t test, and standard deviation.
Results: The analyses revealed a significant increase in obesity prevalence among women with BC. These findings indicate that obese women are at increased risk of developing BC, highlighting obesity as a potential risk factor for this disease.
Conclusion: The findings of this study underscore that obesity is a considerable risk factor linked to an increased probability of BC development in women. Statistical analysis confirmed that obesity rates were significantly higher among women diagnosed with BC. These findings support the notion that excess weight may significantly contribute to the onset and progression of the disease. Evidence suggests that obesity influences various biological processes contributing to cancer, including chronic inflammation, hormonal changes, and elevated insulin levels. Emphasizing obesity as a risk factor for BC is crucial for developing effective prevention and treatment strategies.
References
Bray, F., Ferlay, J., Soerjomataram, I., Siegel, R. L., Torre, L. A., & Jemal, A. (2018). Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA: a cancer journal for clinicians, 68(6), 394-424.
Calle, E. E., Rodriguez, C., Walker-Thurmond, K., & Thun, M. J. (2003). Overweight, obesity, and mortality from cancer in a prospectively studied cohort of US adults. New England Journal of Medicine, 348(17), 1625-1638.
Renehan, A. G., Tyson, M., Egger, M., Heller, R. F., & Zwahlen, M. (2008). Body-mass index and incidence of cancer: a systematic review and meta-analysis of prospective observational studies. The lancet, 371(9612), 569-578.
Ligibel, J. A., Alfano, C. M., Courneya, K. S., Demark-Wahnefried, W., Burger, R. A., Chlebowski, R. T., ... & Hudis, C. A. (2014). American Society of Clinical Oncology position statement on obesity and cancer. Journal of clinical oncology, 32(31), 3568-3574.
Sung, H., Siegel, R. L., Torre, L. A., Pearson‐Stuttard, J., Islami, F., Fedewa, S. A., ... & Jemal, A. (2019). Global patterns in excess body weight and the associated cancer burden. CA: a cancer journal for clinicians, 69(2), 88-112.
Krupa-Kotara, K., & Dakowska, D. (2021). Impact of obesity on risk of cancer. Central European Jour7]nal of Public Health, 29(1), 38-44.
Divella, R., De Luca, R., Abbate, I., Naglieri, E., & Daniele, A. (2016). Obesity and cancer: the role of adipose tissue and adipo-cytokines-induced chronic inflammation. Journal of Cancer, 7(15), 2346.
Kwiatkowska, K., Pawłowska, A., Suszczyk, D., Bilska, M., Tarkowski, R., Kotarski, J., & Wertel, I. (2017). Does obesity increase the risk of ovarian cancer? A literature review. Curr. Gynecol. Oncol, 15, 277-283.
Fujita, K., Hayashi, T., Matsushita, M., Uemura, M., & Nonomura, N. (2019). Obesity, inflammation, and prostate cancer. Journal of clinical medicine, 8(2), 201.
Walczak, K., Marciniak, S., & Rajtar, G. (2017). Cancer chemoprevention–selected molecular mechanisms. Advances in Hygiene and Experimental Medicine, 71, 149-161.
Divella, R., Mazzocca, A., Daniele, A., Sabbà, C., & Paradiso, A. (2019). Obesity, nonalcoholic fatty liver disease and adipocytokines network in promotion of cancer. International journal of biological sciences, 15(3), 610.
Hursting, S. D., DiGiovanni, J., Dannenberg, A. J., Azrad, M., LeRoith, D., Demark-Wahnefried, W., ... & Berger, N. A. (2012). Obesity, energy balance, and cancer: new opportunities for prevention. Cancer prevention research, 5(11), 1260-1272.
Lashinger, L. M., Ford, N. A., & Hursting, S. D. (2014). Interacting inflammatory and growth factor signals underlie the obesity-cancer link. The Journal of nutrition, 144(2), 109-113.
Hopkins, B. D., Goncalves, M. D., & Cantley, L. C. (2016). Obesity and cancer mechanisms: cancer metabolism. Journal of clinical oncology, 34(35), 4277-4283.
Fu, J., Hofker, M., & Wijmenga, C. (2015). Apple or pear: size and shape matter. Cell metabolism, 21(4), 507-508.
Jung, U. J., & Choi, M. S. (2014). Obesity and its metabolic complications: the role of adipokines and the relationship between obesity, inflammation, insulin resistance, dyslipidemia and nonalcoholic fatty liver disease. International journal of molecular sciences, 15(4), 6184-6223.
Othman EM, Oli RG, Arias-Loza PA, Kreissl MC, Stopper H. Metformin protects kidney cells from insulin-mediated genotoxicity in vitro and in male zucker diabetic fatty rats. Endocrinology. 2016;157(2):548-59.
Downloads
Received
Revised
Accepted
Published
Data Availability Statement
Data will be provided by the corresponding author upon reasonable request
Issue
Section
License
Copyright (c) 2025 Iraqi Journal of Cancer and Medical Genetics
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
